Enhancing the drug discovery process - Bayesian inference for the analysis and comparison of dose–response experiments

Abstract

The efficacy of a chemical compound is often tested through dose–response experiments from which efficacy metrics, such as the IC50, can be derived. The Marquardt–Levenberg algorithm (non-linear regression) is commonly used to compute estimations for these metrics. The analysis are however limited and can lead to biased conclusions. The approach does not evaluate the certainty (or uncertainty) of the estimates nor does it allow for the statistical comparison of two datasets. To compensate for these shortcomings, intuition plays an important role in the interpretation of results and the formulations of conclusions. We here propose a Bayesian inference methodology for the analysis and comparison of dose–response experiments.Our results well demonstrate the informativeness gain of our Bayesian approach in comparison to the commonly used Marquardt–Levenberg algorithm. It is capable to characterize the noise of dataset while inferring probable values distributions for the efficacy metrics. It can also evaluate the difference between the metrics of two datasets and compute the probability that one value is greater than the other. The conclusions that can be drawn from such analyzes are more precise.We implemented a simple web interface that allows the users to analyze a single dose–response dataset, as well as to statistically compare the metrics of two datasets.,

Publication
Bioinformatics
Caroline Labelle
Caroline Labelle
PhD student in Bioinformatics

Doctoral student in Bioinformatics | Using Bayesian inference for the analysis of dose-response experiments

Sébastien Lemieux
Sébastien Lemieux
Principal Investigator

Principal Investigator, Functional and Structural Bioinformatics Research Unit, IRIC | Scientific direction of the Bioinformatics platform | Associate Professor, Department of Biochemistry and Molecular Medicine, Université de Montréal